Members
- Teresa Amaral (Chair)
- Reinhard Dummer (Chair)
- Petr Arenberger
- Christoffer Gebhardt
- Josep Malvehy
- Susana Puig
- Ketty Peris
- Caroline Robert
- Philippe Saiag
Scope and objectives
The EADO Task Force Prognostic Biomarkers in Melanoma aims to streamline cooperation between EADO researchers, academic centers and the industry involved in biomarkers and innovative therapies worldwide. The Task Force aims to facilitate the discovery of new biomarkers in skin cancer and participate in the study and clinical validation.
The group’s primary objectives are:
- to facilitate cooperative research in biomarkers with skin cancer centers
- to collaborate with the industry for the evaluation, validation, and market approval of biomarkers
- to elaborate reviews and position papers about biomarkers
- to participate in the elaboration of chapters in biomarkers in EADO Guidelines